Skip to main content
David Wirta, MD, Ophthalmology, Newport Beach, CA

DavidLWirtaMD

Ophthalmology Newport Beach, CA

Oculo-Plastic & Orbital Reconstructive Surgery

Pres./CEO, Eye Research Foundation

Dr. Wirta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wirta's full profile

Already have an account?

  • Office

    520 Superior Ave
    Ste 235
    Newport Beach, CA 92663
    Phone+1 949-650-1863
    Fax+1 949-650-4359

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
    UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 1994 - 1997
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 1993 - 1994
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1993

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1997 - Present
  • CA State Medical License
    CA State Medical License 1995 - 2026
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration with Visual Field in Acquired Ptosis  
    Charles B Slonim, Michael S Korenfeld, Robert Smyth-Medina, David L Wirta, JAMA Ophthalmology

Press Mentions

  • Understanding Meibomian Gland Dysfunction as a Driver for Dry Eye Disease
    Understanding Meibomian Gland Dysfunction as a Driver for Dry Eye DiseaseFebruary 14th, 2023
  • Mallinckrodt : Acthar Gel Phase 4 Keratitis ARVO Poster
    Mallinckrodt : Acthar Gel Phase 4 Keratitis ARVO PosterMay 2nd, 2021
  • Visus Therapeutics Initiates Phase 2 Clinical Trial of BRIMOCHOL for the Treatment of Presbyopia
    Visus Therapeutics Initiates Phase 2 Clinical Trial of BRIMOCHOL for the Treatment of PresbyopiaMarch 25th, 2021
  • Join now to see all

Professional Memberships